Kiniksa(KNSA) - 2025 Q4 - Earnings Call Transcript

Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsGeoff Meacham - Managing DirectorJohn Paolini - Chief Medical OfficerJonathan Kirshenbaum - Senior Manager of Investor RelationsMark Ragosa - CFONick Lorusso - VP of Biotech Equity ResearchRoss Moat - COOSanj Patel - CEOConference Call ParticipantsEva Fortea - Executive Director and Senior Biotechnology AnalystJoysree Zanfir - AnalystRoger Song - Senior Equity Research AnalystOperato ...